[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612224":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":45,"centralContacts":49,"locations":55,"responsibleParty":651,"collaborators":41,"id":653,"slug":654,"hasResults":655,"nctId":656,"briefTitle":657,"officialTitle":658,"acronym":41,"eligibilityCriteria":659,"healthyVolunteers":655,"sex":660,"minAge":661,"maxAge":662,"enrollmentInfo":663,"targetDuration":41,"studyType":666,"phases":667,"briefSummary":669,"conditions":670,"keywords":672,"overallStatus":58,"whyStopped":41,"lastUpdateSubmitDate":674,"lastUpdatePostDateStruct":675,"startDateStruct":678,"completionDateStruct":680,"leadSponsor":682,"locationsCount":683},{"fullName":5,"class":6},"Takeda","INDUSTRY",[8,14,18,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Part A (Cohort 1): Zasocitinib (Dose A)","EXPERIMENTAL","Participants (Adolescent) aged 12 to less than (\\\u003C)18 years will receive zasocitinib Dose A once daily (QD), orally, from Week 1 to Week 16 during the double-blind placebo-controlled period followed by zasocitinib, from Week 16 to Week 208 during the open-label period.",[13],"Drug: Zasocitinib",{"label":15,"type":10,"description":16,"interventionNames":17},"Part A (Cohort 2): Zasocitinib (Multiple Doses)","Participants (Children) aged 4 to \\\u003C12 years will receive zasocitinib, orally, doses based on weight, from Week 1 to Week 16 during the double-blind placebo-controlled period followed by zasocitinib from Week 16 to Week 208 during the open-label period.",[13],{"label":19,"type":20,"description":21,"interventionNames":22},"Part A (Cohort 1 and Cohort 2): Placebo","PLACEBO_COMPARATOR","Participants in Cohort 1 (Adolescent aged 12 to \\\u003C18 years) and Cohort 2 (Children aged 4 to \\\u003C12 years) will receive zasocitinib matching placebo QD from Week 1 to Week 16 during the double-blind placebo-controlled period.",[23],"Drug: Placebo",{"label":25,"type":10,"description":26,"interventionNames":27},"Part B: Zasocitinib (Multiple Doses)","Participants (Children) aged 4 to \\\u003C12 years will receive zasocitinib, orally, doses based on weight, from Week 1 to Week 208 during the open-label period.",[13],[29,37,42],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","Zasocitinib","Zasocitinib.",[9],[35,36],"TAK-279","NDI-034858",{"type":30,"name":38,"description":39,"armGroupLabels":40,"otherNames":41},"Placebo","Zasocitinib matching placebo.",[19],null,{"type":30,"name":31,"description":32,"armGroupLabels":43,"otherNames":44},[15,25],[35,36],[46],{"name":47,"affiliation":5,"role":48},"Study Director","STUDY_DIRECTOR",[50],{"name":51,"role":52,"phone":53,"phoneExt":41,"email":54},"Takeda Contact","CONTACT","+1-877-825-3327","medinfoUS@takeda.com",[56,77,93,109,125,141,156,168,184,200,215,230,247,263,278,293,304,318,335,350,365,379,393,407,424,438,452,469,479,490,504,515,533,549,565,579,593,605,622,637],{"facility":57,"status":58,"city":59,"state":60,"zip":61,"country":62,"countryCode":63,"cosmosGeoPoint":64,"geoPoint":69,"contacts":70},"Exalt Clinical Research","RECRUITING","Chula Vista","California","91910","United States","US",{"type":65,"coordinates":66},"Point",[67,68],-117.0842,32.64005,{"lat":68,"lon":67},[71,74],{"name":72,"role":52,"phone":41,"phoneExt":41,"email":73},"Site Contact","jmckesey@exaltresearch.com",{"name":75,"role":76,"phone":41,"phoneExt":41,"email":41},"Jaqueline McKesey","PRINCIPAL_INVESTIGATOR",{"facility":78,"status":58,"city":79,"state":60,"zip":80,"country":62,"countryCode":63,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"First OC Dermatology Research Inc.","Fountain Valley","92708",{"type":65,"coordinates":82},[83,84],-117.95367,33.70918,{"lat":84,"lon":83},[87,91],{"name":88,"role":52,"phone":89,"phoneExt":41,"email":90},"Site contact","714-531-2966","vivian.laquer@firstocdermresearch.com",{"name":92,"role":76,"phone":41,"phoneExt":41,"email":41},"Vivian Laquer",{"facility":94,"status":58,"city":95,"state":96,"zip":97,"country":62,"countryCode":63,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Direct Helpers Medical Center","Hialeah","Florida","33012",{"type":65,"coordinates":99},[100,101],-80.27811,25.8576,{"lat":101,"lon":100},[104,107],{"name":72,"role":52,"phone":105,"phoneExt":41,"email":106},"305-324-2110","Don@dhrtrials.com",{"name":108,"role":76,"phone":41,"phoneExt":41,"email":41},"Frank Don",{"facility":110,"status":58,"city":111,"state":112,"zip":113,"country":62,"countryCode":63,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Arlington Dermatology","Rolling Meadows","Illinois","60008-3811",{"type":65,"coordinates":115},[116,117],-88.01313,42.08419,{"lat":117,"lon":116},[120,123],{"name":72,"role":52,"phone":121,"phoneExt":41,"email":122},"847-392-5440","bukhalom@hotmail.com",{"name":124,"role":76,"phone":41,"phoneExt":41,"email":41},"Michael Bukhalo",{"facility":126,"status":58,"city":127,"state":128,"zip":129,"country":62,"countryCode":63,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"Apex Clinical Research Center, LLC","Canton","Ohio","44718",{"type":65,"coordinates":131},[132,133],-81.37845,40.79895,{"lat":133,"lon":132},[136,139],{"name":88,"role":52,"phone":137,"phoneExt":41,"email":138},"440-940-2739","jgarcia@apexskin.com",{"name":140,"role":76,"phone":41,"phoneExt":41,"email":41},"Jorge Garcia-Zuazaga",{"facility":142,"status":58,"city":143,"state":128,"zip":144,"country":62,"countryCode":63,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Wright State Physicians","Fairborn","45324",{"type":65,"coordinates":146},[147,148],-84.01938,39.82089,{"lat":148,"lon":147},[151,154],{"name":88,"role":52,"phone":152,"phoneExt":41,"email":153},"937-245-7500","craig.rohan@wright.edu",{"name":155,"role":76,"phone":41,"phoneExt":41,"email":41},"Craig Rohan",{"facility":126,"status":58,"city":157,"state":128,"zip":158,"country":62,"countryCode":63,"cosmosGeoPoint":159,"geoPoint":163,"contacts":164},"Mayfield Heights","44124-4005",{"type":65,"coordinates":160},[161,162],-81.4579,41.51922,{"lat":162,"lon":161},[165,167],{"name":88,"role":52,"phone":166,"phoneExt":41,"email":138},"440-352-7546",{"name":140,"role":76,"phone":41,"phoneExt":41,"email":41},{"facility":169,"status":58,"city":170,"state":171,"zip":172,"country":62,"countryCode":63,"cosmosGeoPoint":173,"geoPoint":177,"contacts":178},"Medical University of South Carolina","Charleston","South Carolina","29425",{"type":65,"coordinates":174},[175,176],-79.93275,32.77632,{"lat":176,"lon":175},[179,182],{"name":88,"role":52,"phone":180,"phoneExt":41,"email":181},"843-876-0110","winelee@musc.edu",{"name":183,"role":76,"phone":41,"phoneExt":41,"email":41},"Lara Wine Lee",{"facility":185,"status":186,"city":187,"state":188,"zip":189,"country":62,"countryCode":63,"cosmosGeoPoint":190,"geoPoint":194,"contacts":195},"UT Physicians Dermatology - Bellaire Station","NOT_YET_RECRUITING","Bellaire","Texas","77401",{"type":65,"coordinates":191},[192,193],-95.45883,29.70579,{"lat":193,"lon":192},[196,198],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":197},"adelaide.a.hebert@uth.tmc.edu",{"name":199,"role":76,"phone":41,"phoneExt":41,"email":41},"Adelaide Hebert",{"facility":201,"status":58,"city":202,"state":188,"zip":203,"country":62,"countryCode":63,"cosmosGeoPoint":204,"geoPoint":208,"contacts":209},"Texas Dermatology and Laser Specialists-San Antonio","San Antonio","78218-3128",{"type":65,"coordinates":205},[206,207],-98.49363,29.42412,{"lat":207,"lon":206},[210,213],{"name":88,"role":52,"phone":211,"phoneExt":41,"email":212},"210-852-2779","drbrowning@texasdls.com",{"name":214,"role":76,"phone":41,"phoneExt":41,"email":41},"John Browning",{"facility":216,"status":58,"city":217,"state":218,"zip":219,"country":62,"countryCode":63,"cosmosGeoPoint":220,"geoPoint":224,"contacts":225},"Medical College of Wisconsin","Milwaukee","Wisconsin","53226",{"type":65,"coordinates":221},[222,223],-87.90647,43.0389,{"lat":223,"lon":222},[226,228],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":227},"kholland@mcw.edu",{"name":229,"role":76,"phone":41,"phoneExt":41,"email":41},"Kristen Holland",{"facility":231,"status":58,"city":232,"state":233,"zip":234,"country":235,"countryCode":236,"cosmosGeoPoint":237,"geoPoint":241,"contacts":242},"Beijing Children Hospital, Capital Medical University","Beijing","Beijing Municipality","100045","China","CN",{"type":65,"coordinates":238},[239,240],116.39723,39.9075,{"lat":240,"lon":239},[243,245],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":244},"zigangxupek@163.com",{"name":246,"role":76,"phone":41,"phoneExt":41,"email":41},"Zigang Xu",{"facility":248,"status":58,"city":249,"state":250,"zip":251,"country":235,"countryCode":236,"cosmosGeoPoint":252,"geoPoint":256,"contacts":257},"Dermatology Hospital of Southern Medical University","Guangzhou","Guangdong","510091",{"type":65,"coordinates":253},[254,255],113.25,23.11667,{"lat":255,"lon":254},[258,261],{"name":72,"role":52,"phone":259,"phoneExt":41,"email":260},"8613763359607","wxh_21773@163.com",{"name":262,"role":76,"phone":41,"phoneExt":41,"email":41},"Xiaohua Wang",{"facility":264,"status":58,"city":265,"state":266,"zip":267,"country":235,"countryCode":236,"cosmosGeoPoint":268,"geoPoint":272,"contacts":273},"Hunan Children's Hospital","Changsha","Hunan","410007",{"type":65,"coordinates":269},[270,271],112.97087,28.19874,{"lat":271,"lon":270},[274,276],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":275},"34438881@qq.com",{"name":277,"role":76,"phone":41,"phoneExt":41,"email":41},"Zhu Wei",{"facility":279,"status":58,"city":280,"state":281,"zip":282,"country":235,"countryCode":236,"cosmosGeoPoint":283,"geoPoint":287,"contacts":288},"Hangzhou First People's Hospital","Hangzhou","Zhejiang","310006",{"type":65,"coordinates":284},[285,286],120.16142,30.29365,{"lat":286,"lon":285},[289,291],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":290},"limingwu1973@163.com",{"name":292,"role":76,"phone":41,"phoneExt":41,"email":41},"Liming Wu",{"facility":294,"status":58,"city":232,"state":41,"zip":295,"country":235,"countryCode":236,"cosmosGeoPoint":296,"geoPoint":298,"contacts":299},"Peking University Third Hospital","100191",{"type":65,"coordinates":297},[239,240],{"lat":240,"lon":239},[300,302],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":301},"wwh0608@126.com",{"name":303,"role":76,"phone":41,"phoneExt":41,"email":41},"Wenhui Wang",{"facility":305,"status":58,"city":306,"state":41,"zip":307,"country":235,"countryCode":236,"cosmosGeoPoint":308,"geoPoint":312,"contacts":313},"Huashan Hospital Fudan University","Shanghai","200040",{"type":65,"coordinates":309},[310,311],121.45806,31.22222,{"lat":311,"lon":310},[314,316],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":315},"xjhhsyy@163.com",{"name":317,"role":76,"phone":41,"phoneExt":41,"email":41},"Jinhua Xu",{"facility":319,"status":186,"city":320,"state":321,"zip":322,"country":323,"countryCode":324,"cosmosGeoPoint":325,"geoPoint":329,"contacts":330},"Johann Wolfgang Goethe-Universität Frankfurt am Main","Frankfurt am Main","Hesse","60596","Germany","DE",{"type":65,"coordinates":326},[327,328],8.68417,50.11552,{"lat":328,"lon":327},[331,333],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":332},"Andreas.Pinter@unimedizin-ffm.de",{"name":334,"role":76,"phone":41,"phoneExt":41,"email":41},"Andreas Pinter",{"facility":336,"status":58,"city":337,"state":338,"zip":339,"country":323,"countryCode":324,"cosmosGeoPoint":340,"geoPoint":344,"contacts":345},"Fachklinik Bad Bentheim","Bad Bentheim","Lower Saxony","48455",{"type":65,"coordinates":341},[342,343],7.15763,52.30066,{"lat":343,"lon":342},[346,348],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":347},"a.tsianakas@fk-bentheim.de",{"name":349,"role":76,"phone":41,"phoneExt":41,"email":41},"Athanasios Tsianakas",{"facility":351,"status":186,"city":352,"state":353,"zip":354,"country":323,"countryCode":324,"cosmosGeoPoint":355,"geoPoint":359,"contacts":360},"Uniklinik Koln, Klinik fur Dermatologie und Venerologie","Cologne","North Rhine-Westphalia","50937",{"type":65,"coordinates":356},[357,358],6.95,50.93333,{"lat":358,"lon":357},[361,363],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":362},"daniela.neumayer@uk-koeln.de",{"name":364,"role":76,"phone":41,"phoneExt":41,"email":41},"Daniela Neumayer",{"facility":366,"status":186,"city":367,"state":353,"zip":368,"country":323,"countryCode":324,"cosmosGeoPoint":369,"geoPoint":373,"contacts":374},"University Hospital of Muenster","Münster","48145",{"type":65,"coordinates":370},[371,372],7.62571,51.96236,{"lat":372,"lon":371},[375,377],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":376},"nina.magnolo@ukmuenster.de",{"name":378,"role":76,"phone":41,"phoneExt":41,"email":41},"Nina Magnolo",{"facility":380,"status":186,"city":381,"state":41,"zip":382,"country":323,"countryCode":324,"cosmosGeoPoint":383,"geoPoint":387,"contacts":388},"Universitätsklinikum Bonn","Bonn","53127",{"type":65,"coordinates":384},[385,386],7.09549,50.73438,{"lat":386,"lon":385},[389,391],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":390},"dagmar.wilsmann-theis@ukb.uni-bonn.de",{"name":392,"role":76,"phone":41,"phoneExt":41,"email":41},"Dagmar Wilsmann-Theis",{"facility":394,"status":186,"city":395,"state":41,"zip":396,"country":323,"countryCode":324,"cosmosGeoPoint":397,"geoPoint":401,"contacts":402},"Universitaetsmedizin der Johannes - Gutenberg Universitaet Mainz","Mainz","55131",{"type":65,"coordinates":398},[399,400],8.28008,49.98185,{"lat":400,"lon":399},[403,405],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":404},"petra.staubach@unimedizin-mainz.de",{"name":406,"role":76,"phone":41,"phoneExt":41,"email":41},"Petra Staubach-Renz",{"facility":408,"status":186,"city":409,"state":410,"zip":411,"country":412,"countryCode":413,"cosmosGeoPoint":414,"geoPoint":418,"contacts":419},"Presidio Ospedaliero Gaspare Rodolico","Catania","Sicily","95123","Italy","IT",{"type":65,"coordinates":415},[416,417],15.07041,37.49223,{"lat":417,"lon":416},[420,422],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":421},"gimicali1@hotmail.it",{"name":423,"role":76,"phone":41,"phoneExt":41,"email":41},"Giuseppe Micali",{"facility":425,"status":186,"city":426,"state":41,"zip":427,"country":412,"countryCode":413,"cosmosGeoPoint":428,"geoPoint":432,"contacts":433},"Universita Degli Studi Di Padova","Padova","35121",{"type":65,"coordinates":429},[430,431],11.14261,44.38225,{"lat":431,"lon":430},[434,436],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":435},"anna.bellonifortina@unipd.it",{"name":437,"role":76,"phone":41,"phoneExt":41,"email":41},"Anna Belloni Fortina",{"facility":439,"status":186,"city":440,"state":41,"zip":441,"country":412,"countryCode":413,"cosmosGeoPoint":442,"geoPoint":446,"contacts":447},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","Rome","00168",{"type":65,"coordinates":443},[444,445],12.51133,41.89193,{"lat":445,"lon":444},[448,450],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":449},"Ketty.Peris@unicatt.it",{"name":451,"role":76,"phone":41,"phoneExt":41,"email":41},"Ketty Peris",{"facility":453,"status":58,"city":454,"state":455,"zip":456,"country":457,"countryCode":458,"cosmosGeoPoint":459,"geoPoint":463,"contacts":464},"Nagoya City University Hospital","Nagoya","Aichi-ken","467-8602","Japan","JP",{"type":65,"coordinates":460},[461,462],136.90641,35.18147,{"lat":462,"lon":461},[465,467],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":466},"akimichi_morita@mac.com",{"name":468,"role":76,"phone":41,"phoneExt":41,"email":41},"Akimichi Morita",{"facility":470,"status":58,"city":471,"state":472,"zip":473,"country":457,"countryCode":458,"cosmosGeoPoint":41,"geoPoint":41,"contacts":474},"Hospital of the University of Occupational and Environmental Health, Japan","Kitakyushu-shi","Fukuoka","807-8555",[475,477],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":476},"long-ago@med.uoeh-u.ac.jp",{"name":478,"role":76,"phone":41,"phoneExt":41,"email":41},"Yuu Sawada",{"facility":480,"status":58,"city":481,"state":482,"zip":483,"country":457,"countryCode":458,"cosmosGeoPoint":41,"geoPoint":41,"contacts":484},"Mie University Hospital","Tsu, Mie","Mie-ken","514-8507",[485,488],{"name":88,"role":52,"phone":486,"phoneExt":41,"email":487},"81 (0) 59-231-5025","yamake@clin.medic.mie-u.ac.jp",{"name":489,"role":76,"phone":41,"phoneExt":41,"email":41},"Keiichi Yamanaka",{"facility":491,"status":58,"city":492,"state":492,"zip":493,"country":457,"countryCode":458,"cosmosGeoPoint":494,"geoPoint":498,"contacts":499},"Nippon Life Hospital","Osaka","550-0006",{"type":65,"coordinates":495},[496,497],135.50107,34.69379,{"lat":497,"lon":496},[500,502],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":501},"higashiyama.mari@nissay-hp.or.jp",{"name":503,"role":76,"phone":41,"phoneExt":41,"email":41},"Mari Higashiyama",{"facility":505,"status":58,"city":506,"state":507,"zip":508,"country":457,"countryCode":458,"cosmosGeoPoint":41,"geoPoint":41,"contacts":509},"Teikyo University Hospital","Itabashi-Ku","Tokyo","173-0003",[510,513],{"name":88,"role":52,"phone":511,"phoneExt":41,"email":512},"818888888888","tada@df6.so-net.ne.jp",{"name":514,"role":76,"phone":41,"phoneExt":41,"email":41},"Yayoi Tada",{"facility":516,"status":58,"city":517,"state":518,"zip":519,"country":520,"countryCode":521,"cosmosGeoPoint":522,"geoPoint":526,"contacts":527},"Cityclinic Przychodnia lekarsko psychologiczna Matusiak sp.p","Wroclaw","Lower Silesian Voivodeship","50-566","Poland","PL",{"type":65,"coordinates":523},[524,525],17.03006,51.10286,{"lat":525,"lon":524},[528,531],{"name":88,"role":52,"phone":529,"phoneExt":41,"email":530},"+48601534853","jacek.szepietowski.work@gmail.com",{"name":532,"role":76,"phone":41,"phoneExt":41,"email":41},"Jacek Szepietowski",{"facility":534,"status":58,"city":535,"state":536,"zip":537,"country":520,"countryCode":521,"cosmosGeoPoint":538,"geoPoint":542,"contacts":543},"Luxderm Specjalistyczny Gabinet Dermatologiczny Dorota Krasowska","Lublin","Lublin Voivodeship","20-573",{"type":65,"coordinates":539},[540,541],22.57009,51.25058,{"lat":541,"lon":540},[544,547],{"name":88,"role":52,"phone":545,"phoneExt":41,"email":546},"48608098578","dor.krasowska@gmail.com",{"name":548,"role":76,"phone":41,"phoneExt":41,"email":41},"Dorota Krasowska",{"facility":550,"status":58,"city":551,"state":552,"zip":553,"country":520,"countryCode":521,"cosmosGeoPoint":554,"geoPoint":558,"contacts":559},"Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie","Rzeszów","Podkarpackie Voivodeship","35-055",{"type":65,"coordinates":555},[556,557],21.99901,50.04132,{"lat":557,"lon":556},[560,563],{"name":88,"role":52,"phone":561,"phoneExt":41,"email":562},"48587192222","adi_medicalis@go2.pl",{"name":564,"role":76,"phone":41,"phoneExt":41,"email":41},"Aleksandra Okuniewska",{"facility":566,"status":58,"city":567,"state":568,"zip":569,"country":520,"countryCode":521,"cosmosGeoPoint":570,"geoPoint":574,"contacts":575},"Centrum Badan Klinicznych Pi-house Sp. Z O. O.","Gdansk","Pomeranian Voivodeship","80-546",{"type":65,"coordinates":571},[572,573],18.64912,54.35227,{"lat":573,"lon":572},[576,578],{"name":88,"role":52,"phone":561,"phoneExt":41,"email":577},"a.okuniewska@pihouse.pl",{"name":564,"role":76,"phone":41,"phoneExt":41,"email":41},{"facility":580,"status":58,"city":581,"state":41,"zip":582,"country":520,"countryCode":521,"cosmosGeoPoint":583,"geoPoint":587,"contacts":588},"\"DERMED\" Centrum Medyczne Sp. z o. o.","Lodz","90-265",{"type":65,"coordinates":584},[585,586],19.47395,51.77058,{"lat":586,"lon":585},[589,591],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":590},"gabinety@dermed.com.pl",{"name":592,"role":76,"phone":41,"phoneExt":41,"email":41},"Andrzej Kaszuba",{"facility":594,"status":58,"city":581,"state":41,"zip":595,"country":520,"countryCode":521,"cosmosGeoPoint":596,"geoPoint":598,"contacts":599},"Dermoklinika-Centrum Medyczne s.c","90-436",{"type":65,"coordinates":597},[585,586],{"lat":586,"lon":585},[600,603],{"name":88,"role":52,"phone":601,"phoneExt":41,"email":602},"48692065698","joanna.narbutt@onet.pl",{"name":604,"role":76,"phone":41,"phoneExt":41,"email":41},"Joanna Narbutt",{"facility":606,"status":58,"city":607,"state":608,"zip":609,"country":610,"countryCode":611,"cosmosGeoPoint":612,"geoPoint":616,"contacts":617},"Complejo Hospitalario Universitario de Santiago de Compostela","Santiago de Compostela","A Coruna","15706","Spain","ES",{"type":65,"coordinates":613},[614,615],-8.54569,42.88052,{"lat":615,"lon":614},[618,620],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":619},"Maria.Isabel.Rodriguez.Blanco@sergas.es",{"name":621,"role":76,"phone":41,"phoneExt":41,"email":41},"Maria Isabel Rodriguez Blanco",{"facility":623,"status":186,"city":624,"state":41,"zip":625,"country":610,"countryCode":611,"cosmosGeoPoint":626,"geoPoint":630,"contacts":631},"Hospital de La Santa Creu i Sant Pau - Dermatologia","Barcelona","08041",{"type":65,"coordinates":627},[628,629],2.15899,41.38879,{"lat":629,"lon":628},[632,635],{"name":88,"role":52,"phone":633,"phoneExt":41,"email":634},"34935537007","alopezfe@santpau.cat",{"name":636,"role":76,"phone":41,"phoneExt":41,"email":41},"Anna Lopez Ferrer",{"facility":638,"status":186,"city":639,"state":41,"zip":640,"country":610,"countryCode":611,"cosmosGeoPoint":641,"geoPoint":645,"contacts":646},"Hospital Universitario 12 de Octubre","Madrid","28041",{"type":65,"coordinates":642},[643,644],-3.70256,40.4165,{"lat":644,"lon":643},[647,649],{"name":88,"role":52,"phone":41,"phoneExt":41,"email":648},"rriveradiaz@hotmail.com",{"name":650,"role":76,"phone":41,"phoneExt":41,"email":41},"Raquel Rivera-Diaz",{"type":652,"investigatorFullName":41,"investigatorTitle":41,"investigatorAffiliation":41,"oldNameTitle":41,"oldOrganization":41},"SPONSOR","100612224","phase-3-a-long-term-study-of-zasocitinib-in-children-and-teenagers-with-plaque-psoriasis-100612224",false,"NCT07250802","A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis","A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Zasocitinib in Pediatric Participants Aged 4 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis","Inclusion Criteria:\n\n1. Participant has a diagnosis of chronic plaque psoriasis for greater than or equal to (\\>=) 6 months prior to the screening visit.\n2. Participant has stable plaque psoriasis defined as no significant flare or change in morphology (as assessed by the investigator) in psoriasis for \\>=6 months before screening.\n3. Participant has moderate-to-severe plaque psoriasis as defined by a Psoriasis Area and Severity Index (PASI) score \\>=12 and a Static Physician's Global Assessment (sPGA) score \\>=3 at screening and Day 1.\n4. Participant has plaque psoriasis covering \\>=10 percent (%) of total body surface area (BSA) at screening and Day 1.\n5. Participant must be a candidate for phototherapy or systemic therapy.\n6. Inclusion Criteria for Part A Cohort 1: The participant is male or female and aged 12 to less than (\\\u003C) 18 years, inclusive.\n7. Inclusion Criteria for Part A Cohort 2 and for Part B: The participant is male or female and aged 4 to \\\u003C12 years, inclusive.\n8. Inclusion Criteria for Part A Cohort 1: The participant must weigh \\>=40 kilograms (kg) at the time of screening.\n\nExclusion Criteria:\n\n1. Participant has evidence of nonplaque psoriasis (erythrodermic, pustular, predominantly guttate psoriasis, predominantly inverse, or drug-induced psoriasis). If a participant meets criteria for inclusion based on typical plaque psoriasis presentation, a limited amount of inverse psoriasis is not exclusionary.\n2. Participant requires systemic treatment, other than nonsteroidal anti-inflammatory drugs (NSAIDs), during the trial period for an immune-related disease.\n3. Participant has concomitant comorbid skin condition that, in the opinion of the investigator, would interfere with the trial assessments.\n4. Participant has history of active TB infection, regardless of treatment status and has signs or symptoms of active TB or evidence of latent tuberculosis infection (LTBI).\n5. Participant has active herpes virus infection, including herpes zoster or herpes simplex 1 and 2 or a history of serious herpetic infection.\n6. Participant has a history of chronic or recurrent bacterial disease.\n7. Participant has a history of opportunistic infections (for example, Pneumocystis jirovecii pneumonia, histoplasmosis, coccidiomycosis).\n8. Participant has any clinically significant medical condition, evidence of an unstable clinical condition or vital signs\u002Fphysical examination\u002Flaboratory\u002FECG abnormality that would, in the opinion of the investigator, put the participant at undue risk or interfere with interpretation of trial results.\n9. Participant has any previous exposure to zasocitinib (also known as TAK-279 or NDI-034858) or other TYK2 inhibitors or participated in any trial that included a tyrosine kinase 2 (TYK2) inhibitor, unless participant has documentation of posttrial unblinding that confirms the participant did not receive a TYK2 inhibitor.\n10. Participant is not up to date on all required vaccinations according to current immunization guidelines as noted by country-specific pediatric authorities.\n\nOther protocol-defined inclusion\u002Fexclusion criteria apply.","ALL","4 Years","17 Years",{"count":664,"type":665},110,"ESTIMATED","INTERVENTIONAL",[668],"PHASE3","The main aim of this study is to see how well the medicine zasocitinib works, how safe it is, and how children and teenagers aged 4 to under 18 with moderate-to-severe plaque psoriasis respond to it.\n\nThe study will be done in 2 parts: Part A will include both children and teenagers, while part B will only include children.\n\nAt first, only teenagers who meet the study rules can participate in this study. Children may only start to participate once enough information has been collected from other studies with zasocitinib.\n\nParticipants in Part A will initially be assigned to receive either zasocitinib or placebo for the first 16 weeks of treatment, then all participants will receive zasocitinib through the end of the study. All participants in Part B will be assigned to receive treatment with zasocitinib throughout the study.\n\nParticipants will be in the study for up to 4 years and 2 months (217 weeks), including up to 35 days for the screening period, 208 weeks of treatment (Part A and Part B) and a 4-week safety follow-up period. During the study, participants will visit their study site multiple times.",[671],"Plaque Psoriasis",[673],"Drug Therapy","2026-06-16",{"date":676,"type":677},"2026-06-17","ACTUAL",{"date":679,"type":677},"2025-12-04",{"date":681,"type":665},"2033-01-24",{"name":5,"class":6},40]